Related Experiment Video
Updated: Mar 24, 2026

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
Pterosin B has multiple targets in gluconeogenic programs, including coenzyme Q in RORα-SRC2 signaling
Yumi Itoh1, Hiroyuki Fuchino2, Masato Sanosaka1
1Cell Signaling and Metabolic Disease, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.
Pterosin B, a plant compound, unexpectedly represses glucose-6-phosphatase expression during cAMP signaling by targeting the RORα-SRC2 complex. This compound disrupts the coenzyme Q oxidation-reduction cycle, impacting hepatic gluconeogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Metabolism
Background:
- Hepatic gluconeogenesis is crucial for glucose homeostasis and regulated by signaling cascades like glucagon-cAMP.
- Glucose-6-phosphatase catalytic subunit (G6pc) is a key enzyme in gluconeogenesis.
- Pterosin B from Pteridium aquilinum influences gluconeogenic gene expression via salt-inducible kinase 3 and CREB-regulated transcription coactivator 2.
Purpose of the Study:
- To investigate the paradoxical effect of Pterosin B on G6pc expression under cAMP signaling.
- To identify the molecular targets of Pterosin B in regulating gluconeogenic programs.
- To explore the link between mitochondrial oxidative phosphorylation (OXPHOS) and G6pc regulation.
Main Methods:
- Investigated Pterosin B's effect on G6pc expression in the presence and absence of cAMP.
- Identified transcription factors interacting with Pterosin B using chromatin immunoprecipitation assays.
- Assessed the impact of Pterosin B and OXPHOS inhibitors on the RORα-SRC2 complex and coenzyme Q oxidation-reduction cycle.
Main Results:
- Pterosin B initially promoted G6pc expression but strongly repressed it upon cAMP activation.
- The retinoic acid receptor-related orphan receptor alpha-steroid receptor coactivator 2 (RORα-SRC2) complex on the G6pc promoter was identified as a key target of Pterosin B.
- Pterosin B impaired the coenzyme Q oxidation-reduction cycle in OXPHOS, mimicking antimycin A's effect on RORα-SRC2 signaling.
Conclusions:
- The RORα-SRC2 complex acts as a sensor for the coenzyme Q oxidation-reduction cycle, regulating G6pc expression in hepatic gluconeogenic programs.
- Pterosin B disrupts this sensor mechanism, providing a novel insight into the regulation of gluconeogenesis.
- Mitochondrial OXPHOS components differentially influence transcriptional regulation of gluconeogenic programs.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
05:28Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
Published on: June 2, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...